Analyst Activity – Canaccord Genuity Reiterates Buy on NYSE:ZYME – Zymeworks (NYSE:ZYME)

ME Staff
-
0

Analyst Ratings For NYSE:ZYME – Zymeworks (NYSE:ZYME)

Today, Canaccord Genuity reiterated its Buy rating on NYSE:ZYME – Zymeworks (NYSE:ZYME) with a price target of $18.00 ➝ $21.00.

Some recent analyst ratings include

  • 5/16/2018-Canaccord Genuity Reiterated Rating of Buy.
  • 5/14/2018-Ladenburg Thalmann initiated coverage with a Buy rating.
  • 5/11/2018-Barclays Upgrade from a “Underweight ➝ Equal Weight” rating to a “” rating.
  • 3/19/2018-Raymond James initiated coverage with a Outperform ➝ Outperform rating.
  • 9/30/2017-Cormark Reiterated Rating of Buy.
  • 5/23/2017-Citigroup initiated coverage with a Buy ➝ Buy rating.
  • 5/23/2017-Wells Fargo initiated coverage with a Outperform ➝ Outperform rating.


    Recent Trading Activity for NYSE:ZYME – Zymeworks (NYSE:ZYME)
    Shares of NYSE:ZYME – Zymeworks closed the previous trading session at 17.01 up +0.44 2.66% with shares trading hands.